Bayer AG Company Profile (OTC:BAYRY)

About Bayer AG (OTC:BAYRY)

Bayer AG logoBayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTC:BAYRY
  • CUSIP: N/A
  • Web:
  • Market Cap: $113.78 billion
  • Outstanding Shares: 871,387,000
Average Prices:
  • 52 Week Range: $91.53 - $139.04
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: 13.39
  • P/E Growth:
Sales & Book Value:
  • Annual Revenue: $55.26 billion
  • Price / Sales: 2.06
  • Book Value: $44.27 per share
  • Price / Book: 2.95
  • Annual Dividend: $2.16
  • Dividend Yield: 2.3%
  • EBIDTA: $13.18 billion
  • Net Margins: 10.56%
  • Return on Equity: 21.88%
  • Return on Assets: 7.43%
  • Debt-to-Equity Ratio: 0.69%
  • Current Ratio: 1.53%
  • Quick Ratio: 1.05%
  • Beta: 1.15
Frequently Asked Questions for Bayer AG (OTC:BAYRY)

What is Bayer AG's stock symbol?

Bayer AG trades on the OTC under the ticker symbol "BAYRY."

Who are some of Bayer AG's key competitors?

Who are Bayer AG's key executives?

Bayer AG's management team includes the folowing people:

  • Werner Wenning, Chairman of the Supervisory Board
  • Werner Baumann, Chairman of the Management Board, Chief Executive Officer
  • Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative
  • Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board
  • Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director
  • Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit
  • Kemal Malik, Member of the Management Board, Innovation and the Latin America Region
  • Erica Mann, Member of the Management Board, Head of the Consumer Health Division
  • Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division
  • Paul Achleitner, Member of the Supervisory Board

How do I buy Bayer AG stock?

Shares of Bayer AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer AG's stock price today?

One share of Bayer AG stock can currently be purchased for approximately $130.57.

MarketBeat Community Rating for Bayer AG (OTC BAYRY)
Community Ranking:  1.7 out of 5 ()
Outperform Votes:  1 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  3
MarketBeat's community ratings are surveys of what our community members think about Bayer AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bayer AG (OTC:BAYRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Bayer AG (OTC:BAYRY)
DateFirmActionRatingPrice TargetDetails
7/3/2017Berenberg BankDowngradeBuy -> HoldView Rating Details
(Data available from 7/26/2015 forward)


Earnings History for Bayer AG (OTC:BAYRY)
No earnings announcements for this company have been tracked by


Earnings Estimates for Bayer AG (OTC:BAYRY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171$2.02$2.02$2.02
(Data provided by Zacks Investment Research)


Dividend History for Bayer AG (OTC:BAYRY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Bayer AG (OTC:BAYRY)
No insider trades for this company have been tracked by


Headline Trends for Bayer AG (OTC:BAYRY)
Latest Headlines for Bayer AG (OTC:BAYRY)
DateHeadline logoBayer AG (OTC:BAYRY) Forecasted to Post Q2 2017 Earnings of $2.02 Per Share - July 12 at 8:06 AM logoBerenberg Bank Downgrades Bayer AG (OTC:BAYRY) to Hold - July 3 at 2:39 PM logoBayer Submits Regorafenib For Approval In Second-Line Liver Cancer Treatment - November 8 at 2:14 PM logoBayer to launch ornamentals biz in RTP - November 2 at 12:51 PM logoBayer Q3 Profit Climbs; Lifts FY16 Core Earnings View - Quick Facts - October 27 at 8:13 AM logoTracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2016 Update - October 17 at 8:36 AM logoA Big Fund Is Losing Its Pilot - October 10 at 8:31 AM logoBayer (BAYRY) Closes Registration Process for Kyleena in EU - October 5 at 3:28 PM logoMonsanto's (MON) Q4 Earnings & Revenues Beat Estimates - October 5 at 3:28 PM logoBayer Concludes European Registration Procedure For 5-yr Contraceptive - October 4 at 3:42 PM logoHC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target - September 22 at 3:50 PM logoAgricultural Seed Company Executives Defend Mergers in Washington - September 21 at 7:37 AM logoMonsanto Stock Falls Below Bayer's Offer Price (MON, BAYRY) - September 16 at 8:20 AM logoBayer Reportedly To Raise Offer To About $129/Shr For Monsanto - September 14 at 6:27 AM logoBayer Edges Closer to $65 Billion Deal for Monsanto - September 14 at 6:27 AM logoBayer ups offer again for Monsanto - September 6 at 8:33 AM logoThe Hunt for Monsanto's Magic Beans - September 6 at 8:33 AM logoMonsanto (MON) Stock Up, Bayer Raises Bid - September 6 at 8:33 AM logoMonsanto Shareholders' Best Hope Might be a Hostile Bayer - September 5 at 3:40 PM logoBayer Makes $62 Billion Bid for Monsanto - May 25 at 10:27 AM logoCommerzbank lifts Bayer to buy rating on Monsanto bid - May 25 at 7:15 AM logoIs Bayer's Monsanto Rejection Good News for Shareholders? - May 25 at 6:51 AM logoEuropean Stocks Gain Traction on Greek Debt-Relief Deal - May 25 at 4:55 AM logoBayer Sends a Bear Hug to Monsanto - May 24 at 9:57 AM logoBayer’s Top Managers Swoop in to Buy Stock Amid Monsanto Slump - May 24 at 9:34 AM logoBayer talks RTP investment, Monsanto reputation following $62B takeover bid - May 24 at 8:30 AM logoMonsanto's bad reputation raises questions over Bayer bid - May 24 at 7:20 AM logoBayer Managers Hit the Road to Spell Out Monsanto Bid Rationale - May 24 at 5:45 AM logo[$$] Monsanto did not intend to become a takeover target - May 24 at 5:30 AM logoHere’s How a Bayer-Monsanto Merger Affects Workers, Farmers, and Investors - May 24 at 4:57 AM logoCould Bayer sweeten its Monsanto bid? - May 24 at 4:07 AM logoThe repercussions of the Bayer-Monsanto deal - May 24 at 2:14 AM


This page was last updated on 7/26/2017 by Staff